Overview

Safety Study of ISIS 325568 in Healthy Volunteers

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this trial is to assess the safety of ISIS 325568 when given at increasing single doses and to assess the safety of the same doses when given multiple times.

Phase:

Phase 1

Details

Lead Sponsor:

Ionis Pharmaceuticals, Inc.